Announcements Trials
Browse Landscape

Phase

Phase 3 250Phase 2 216Phase 1 138Phase 1/2 105Phase 2/3 29Phase 4 6Phase NA 4

Status

Completed 3Unknown 2Recruiting 1

Sponsor Class

OTHER 25INDUSTRY 6OTHER_GOV 3UNKNOWN 1NIH 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 3Head & Neck 2Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Squamous Non-small-cell Lung Cancer 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Cisplatin × Clear all
NCT06457503 2026-04-06

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting
100 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT02996214 2020-02-13

LIPUSU

Nanjing Luye Sike Pharmaceutical Co., Ltd.

Phase 4 Unknown
536 enrolled
Thoracic

Squamous Non-small-cell Lung Cancer

NCT02088515 2017-03-03

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

Jiangsu Simcere Pharmaceutical Co., Ltd.

Phase 4 Completed
290 enrolled
Tumor-Agnostic

Carcinoma, Squamous Cell

NCT02000531 2016-01-13

Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population

Hoffmann-La Roche

Phase 4 Completed
45 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02513355 2015-08-04

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Phase 4 Unknown
400 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00772681 2009-12-07

Tax-Nazo

Sanofi

Phase 4 Completed
57 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡